Sipahi, O. R. Et Al. 2023. Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter ephesus study.. BMC infectious diseases , vol.23, no.1 , 639.

Sipahi, O. R., Akyol, D., Ormen, B., Cicek-Senturk, G., Mermer, S., Onal, U., ... Amer, F.(2023). Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter ephesus study.. BMC infectious diseases , vol.23, no.1, 639.

Sipahi, Oguz Et Al. "Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter ephesus study.," BMC infectious diseases , vol.23, no.1, 639, 2023

Sipahi, Oguz R. Et Al. "Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter ephesus study.." BMC infectious diseases , vol.23, no.1, pp.639, 2023

Sipahi, O. R. Et Al. (2023) . "Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter ephesus study.." BMC infectious diseases , vol.23, no.1, p.639.

@article{article, author={Oguz Resat Sipahi Et Al. }, title={Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter ephesus study.}, journal={BMC infectious diseases}, year=2023, pages={639} }